| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/16/2005 | CN1596269A A novel G protein-coupled receptor, gave 10 |
| 03/16/2005 | CN1596266A Specific binding agents of human angiopoietin-2 |
| 03/16/2005 | CN1596257A Novel crystalline compound |
| 03/16/2005 | CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/16/2005 | CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 03/16/2005 | CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
| 03/16/2005 | CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 03/16/2005 | CN1596122A Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 03/16/2005 | CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues |
| 03/16/2005 | CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer |
| 03/16/2005 | CN1596106A Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary disea |
| 03/16/2005 | CN1593641A Externally applied ointment for treating pains of neck, shoulder, waist and limbs and its preparation process |
| 03/16/2005 | CN1593609A Medicinal liquor for treating wind damp and traumatic injury pain |
| 03/16/2005 | CN1593592A Externally applied plaster for treating hyperosteogeny and preparation method thereof |
| 03/16/2005 | CN1593589A Gout treating medicinal pills and its preparation |
| 03/16/2005 | CN1593583A Compound preparation for bone fracture and its preparation method |
| 03/16/2005 | CN1593581A Hyperosteogeny plaster |
| 03/16/2005 | CN1593580A Pain relieving plaster for rheumathritis |
| 03/16/2005 | CN1593576A Medicinal wine for expelling wind, eliminating dampness, relaxing tendon and stopping pain |
| 03/16/2005 | CN1593573A Traumatic injury treating medicine |
| 03/16/2005 | CN1593569A Steaming medicinal liquor for treating intervertebral disc protrusion and hyperosteogeny |
| 03/16/2005 | CN1593568A Medicine for treating burns, scalds, other multiple skin disease and traumatic injury |
| 03/16/2005 | CN1593527A Dispersible tablet of 'Duyiwei' and its preparing method |
| 03/16/2005 | CN1593510A Method for preparing Chinese medicinal formulation of dog button |
| 03/16/2005 | CN1593509A Externally applied Chinese medicinal formulation for treating bone fracture |
| 03/16/2005 | CN1593492A Medicine for treating bone fracture |
| 03/16/2005 | CN1593488A Compound medicinal powder for dredging stagnate meridians |
| 03/16/2005 | CN1593484A Bone strengthening granule of tortoise plastron and astragalus root |
| 03/16/2005 | CN1593474A Chinese medicine composition for treating lumbago and scelalgia and hyperosteogeny and its preparing method |
| 03/16/2005 | CN1593466A Simple prescription of earthworm oral liquid for treating alveolar bone resorption and its preparing method |
| 03/16/2005 | CN1593454A Magnesium, potassium and calcium mixture and its usage |
| 03/16/2005 | CN1593443A Medical phytoestrogen |
| 03/16/2005 | CN1593432A Alendronate sodium powder for injection |
| 03/16/2005 | CN1593389A Cool plaster and its processing method and usage |
| 03/16/2005 | CN1193026C Z-pyrazoline-5-ones |
| 03/16/2005 | CN1193016C Process for synthesizing inhibitor of phosphatidase A2 |
| 03/16/2005 | CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 03/15/2005 | US6867300 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 03/15/2005 | US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents |
| 03/15/2005 | US6867214 Quinazoline derivatives and pharmaceutical applications thereof |
| 03/15/2005 | US6867213 Vitronectin receptor inhibitors; bone diseases, osteoporosis; esterification of acid form with isopropanol |
| 03/15/2005 | US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release |
| 03/15/2005 | US6867208 Vitronectin receptor antagonists, their preparation and their use |
| 03/15/2005 | US6866851 GFRα1-RET specific agonists and methods therefor |
| 03/15/2005 | CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists |
| 03/10/2005 | WO2005021768A1 Aav vectors for in vivo gene therapy of rheumatoid arthritis |
| 03/10/2005 | WO2005021513A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
| 03/10/2005 | WO2005021008A1 Iontophoresis-administered composition |
| 03/10/2005 | WO2005020965A2 Skeletally targeted nanoparticles |
| 03/10/2005 | WO2004098619A3 Treating cartilage / bone conditions with water-soluble strontium salts |
| 03/10/2005 | WO2004041794A8 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 03/10/2005 | WO2003104260A3 Pharmaceutical formulation |
| 03/10/2005 | WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 03/10/2005 | WO2003007875A9 Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
| 03/10/2005 | US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 03/10/2005 | US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis |
| 03/10/2005 | US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 03/10/2005 | US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases |
| 03/10/2005 | US20050054675 Interferon $g(g) production promoter |
| 03/10/2005 | US20050054674 Activator of peroxisome proliferator-activated receptor |
| 03/10/2005 | US20050054637 Prophylaxis, therapy cardiovascular disorders |
| 03/10/2005 | US20050054632 Naphthyl compounds, intermediates, compositions, and methods of use |
| 03/10/2005 | US20050054623 Transdermal supplying testosterone gel |
| 03/10/2005 | US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders |
| 03/10/2005 | US20050054595 Genetic engineering; gene expression of target agent |
| 03/10/2005 | US20050054593 New drug |
| 03/10/2005 | US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases |
| 03/10/2005 | US20050054585 Using saccharide; bone disorders |
| 03/10/2005 | US20050054582 Para-amino benzoic acids as integrin antagonists |
| 03/10/2005 | US20050054563 Transgenic bacteria host cell can be used for screening antibiotics , herbicides; genetic engineering; therapy for bone disorders; antiarthritic agents |
| 03/10/2005 | US20050054041 Kini-3 motor protein and methods for its use |
| 03/10/2005 | US20050054036 Growth factor isoform |
| 03/10/2005 | US20050054016 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/10/2005 | US20050054013 Using purinergic receptor to identify modulators tor prevention and treatment of bone mass and/or bone mineral density disorders |
| 03/10/2005 | US20050053668 allows targeted delivery of bioactive factors to bone using nanocapsules having an amphipathic surface made of polyethylene glycol-modified phospholipid |
| 03/10/2005 | US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis |
| 03/10/2005 | US20050053576 Glycosaminoglycan-polycation complex crosslinked with polyfunctional crosslinking agent and process for producing the same |
| 03/10/2005 | CA2539953A1 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| 03/10/2005 | CA2536471A1 Aav vectors for in vivo gene therapy of rheumatoid arthritis |
| 03/10/2005 | CA2536246A1 Skeletally targeted nanoparticles |
| 03/09/2005 | EP1512739A1 Chrondrocyte therapeutic delivery system |
| 03/09/2005 | EP1512679A1 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them |
| 03/09/2005 | EP1512415A1 Decoy composition for treating and preventing inflammatory disease |
| 03/09/2005 | EP1512401A1 Enhancement of bone growth and inhibition of bone resorption |
| 03/09/2005 | EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 03/09/2005 | EP1511857A1 Pthrp-based prediction and diagnosis of bone disease |
| 03/09/2005 | EP1511853A2 Regulation of novel human asparagine-hydroxylases |
| 03/09/2005 | EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 03/09/2005 | EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors |
| 03/09/2005 | EP1511742A1 Kinase inhibitors |
| 03/09/2005 | EP1511740A1 Phenyl-thiophene type vitamin d receptor modulators |
| 03/09/2005 | EP1511737A1 Aryloximes |
| 03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |
| 03/09/2005 | EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 03/09/2005 | EP1511725A1 24-SULFOXIMINE VITAMIN D sb 3 /sb COMPOUNDS |
| 03/09/2005 | EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/09/2005 | EP1511521A1 Strontium-apatite-cement-preparations and the use thereof |
| 03/09/2005 | EP1511516A1 Topically applicable pharmaceutical preparation |